Carregant...
MiR-429 Inhibits Oral Squamous Cell Carcinoma Growth by Targeting ZEB1
BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth most common human malignancy worldwide. To develop new therapeutics requires elucidation of the underlying mechanism of OSCC pathogenesis. The role of miR-429 in OSCC remains unknown. MATERIAL/METHODS: The level of miR-429 and ZEB1 in OSCC...
Guardat en:
| Publicat a: | Med Sci Monit |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
International Scientific Literature, Inc.
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4324578/ https://ncbi.nlm.nih.gov/pubmed/25640197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.893412 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|